👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
✓ Verified
Trust score 96/100
Accepting new patients
Dr
Dr Crispin Thomas Hiley
Oncology
English
French
13,018+
Patients seen
3
Years in practice
9
Publications
2
Languages spoken
About
Discover Dr. Crispin Hiley: Leading Private Oncologist in London
Dr. Crispin Hiley is an internationally acclaimed oncology expert known for combining advanced scientific research with compassionate patient care. As an Associate Professor in Oncology at University College London and a Consultant Oncologist at University College London Hospital, Dr. Hiley stands at the cutting edge of cancer treatment and research. He also serves as the Clinical Director for Lung Cancer at GenesisCare UK, which provides private healthcare across 14 specialist centers in the UK.
Comprehensive and Personalized Cancer Care
Dr. Hiley is committed to delivering personalized care tailored to each patient’s unique needs. He offers private consultations in London and provides comprehensive chemotherapy and radiotherapy services across the UK. For those who prefer the comfort of their home, Dr. Hiley can arrange for chemotherapy to be administered at home when appropriate.
Expert in Lung Cancer Treatment
Specializing in non-surgical treatments for lung cancer, Dr. Hiley is an authority in:
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Advanced Radiotherapy Techniques, including:
- Volumetric Arc Therapy (VMAT)
- Intensity Modulated Radiotherapy (IMRT)
- Image Guided Radiotherapy (IGRT)
- Proton Therapy
- Stereotactic Radiotherapy (SBRT)
Dr. Hiley’s research includes significant contributions to understanding resistance mechanisms to EGFR inhibitors like Osimertinib and immunotherapies such as Atezolizumab and Pembrolizumab.
[Watch Dr. Hiley Discuss His Research](https://youtu.be/8VqLkjbgtmA?si=hHiD0fOuSCzABUQv)
As the UCLH Lead for Lung Proton Therapy, Dr. Hiley was the first oncologist in the UK to treat lung cancer patients with this innovative technology. He is also the chief investigator of the HIT-MESO trial, which examines the use of Proton Beam Radiotherapy for mesothelioma patients. Through his role with Proton International@UCLH, he offers advanced proton therapy treatments for private patients.
[Learn More About the HIT-MESO Trial](https://crukradnet.colcc.ac.uk/2022/08/11/new-clinical-trial-hemithoracic-irradiation-with-proton-therapy-in-malignant-pleural-mesothelioma-hit-meso/)
Advanced Radiotherapy for Multiple Cancer Types
Dr. Hiley’s expertise extends beyond lung cancer. He specializes in stereotactic radiotherapy (SBRT) for oligo metastatic and oligo progressive diseases in various cancers, including:
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Gynecological Cancers
- Sarcomas
- Lung Cancer
He utilizes the latest technology, including MRI-guided SABR with the ViewRay MRIdian system, to treat challenging tumors. Additionally, Dr. Hiley offers reirradiation therapy for patients who have previously undergone radiotherapy.
[Read More on Stereotactic Radiotherapy](https://www.genesiscare.com/uk/specialists/about-us/innovations-blog/stereotactic-radiotherapy-for-the-management-of-early-stage-lung)
Distinguished Training and Research
Dr. Hiley graduated with honors from the University of Manchester in 2005 and has trained at some of the world’s leading oncology centers, including:
- The Christie Hospital
- MD Anderson Cancer Centre
- Kings College
- The Royal Marsden
He earned his PhD from the University of London and completed postdoctoral fellowships at the Francis Crick Institute and the UCL Cancer Institute.
Since becoming a consultant in 2018, Dr. Hiley has led the clinical oncology lung team at UCLH. His roles include:
- UCLH Lead for Lung Proton Therapy
- Deputy Lead of Clinical Trials for the CRUK Lung Cancer Centre of Excellence
- NIHR Clinical Research Network Specialty Research Lead in Radiotherapy for North London
Dr. Hiley heads a research group focused on overcoming resistance to cancer treatments and is the principal investigator for numerous clinical trials. His work has been featured in prestigious journals like NEJM, The Lancet, Nature, and Cell. He also contributed to the Royal College of Radiologists Consensus Statement on Radiotherapy for Lung Cancer, setting the standard of practice in the UK.
Dr. Crispin Hiley is an internationally acclaimed oncology expert known for combining advanced scientific research with compassionate patient care. As an Associate Professor in Oncology at University College London and a Consultant Oncologist at University College London Hospital, Dr. Hiley stands at the cutting edge of cancer treatment and research. He also serves as the Clinical Director for Lung Cancer at GenesisCare UK, which provides private healthcare across 14 specialist centers in the UK.
Comprehensive and Personalized Cancer Care
Dr. Hiley is committed to delivering personalized care tailored to each patient’s unique needs. He offers private consultations in London and provides comprehensive chemotherapy and radiotherapy services across the UK. For those who prefer the comfort of their home, Dr. Hiley can arrange for chemotherapy to be administered at home when appropriate.
Expert in Lung Cancer Treatment
Specializing in non-surgical treatments for lung cancer, Dr. Hiley is an authority in:
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Advanced Radiotherapy Techniques, including:
- Volumetric Arc Therapy (VMAT)
- Intensity Modulated Radiotherapy (IMRT)
- Image Guided Radiotherapy (IGRT)
- Proton Therapy
- Stereotactic Radiotherapy (SBRT)
Dr. Hiley’s research includes significant contributions to understanding resistance mechanisms to EGFR inhibitors like Osimertinib and immunotherapies such as Atezolizumab and Pembrolizumab.
[Watch Dr. Hiley Discuss His Research](https://youtu.be/8VqLkjbgtmA?si=hHiD0fOuSCzABUQv)
As the UCLH Lead for Lung Proton Therapy, Dr. Hiley was the first oncologist in the UK to treat lung cancer patients with this innovative technology. He is also the chief investigator of the HIT-MESO trial, which examines the use of Proton Beam Radiotherapy for mesothelioma patients. Through his role with Proton International@UCLH, he offers advanced proton therapy treatments for private patients.
[Learn More About the HIT-MESO Trial](https://crukradnet.colcc.ac.uk/2022/08/11/new-clinical-trial-hemithoracic-irradiation-with-proton-therapy-in-malignant-pleural-mesothelioma-hit-meso/)
Advanced Radiotherapy for Multiple Cancer Types
Dr. Hiley’s expertise extends beyond lung cancer. He specializes in stereotactic radiotherapy (SBRT) for oligo metastatic and oligo progressive diseases in various cancers, including:
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Gynecological Cancers
- Sarcomas
- Lung Cancer
He utilizes the latest technology, including MRI-guided SABR with the ViewRay MRIdian system, to treat challenging tumors. Additionally, Dr. Hiley offers reirradiation therapy for patients who have previously undergone radiotherapy.
[Read More on Stereotactic Radiotherapy](https://www.genesiscare.com/uk/specialists/about-us/innovations-blog/stereotactic-radiotherapy-for-the-management-of-early-stage-lung)
Distinguished Training and Research
Dr. Hiley graduated with honors from the University of Manchester in 2005 and has trained at some of the world’s leading oncology centers, including:
- The Christie Hospital
- MD Anderson Cancer Centre
- Kings College
- The Royal Marsden
He earned his PhD from the University of London and completed postdoctoral fellowships at the Francis Crick Institute and the UCL Cancer Institute.
Since becoming a consultant in 2018, Dr. Hiley has led the clinical oncology lung team at UCLH. His roles include:
- UCLH Lead for Lung Proton Therapy
- Deputy Lead of Clinical Trials for the CRUK Lung Cancer Centre of Excellence
- NIHR Clinical Research Network Specialty Research Lead in Radiotherapy for North London
Dr. Hiley heads a research group focused on overcoming resistance to cancer treatments and is the principal investigator for numerous clinical trials. His work has been featured in prestigious journals like NEJM, The Lancet, Nature, and Cell. He also contributed to the Royal College of Radiologists Consensus Statement on Radiotherapy for Lung Cancer, setting the standard of practice in the UK.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Crispin Thomas Hiley
Education & training
-
2013–2019 MD · Medicine and Surgery
-
2019–2023 Residency · Oncology
Career & appointments
-
2023-09–2024-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
AmTrust Europe · 3,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 1,168 |
| Annual physical exam | 99395 | 1,550 |
| Vaccination administration | 90471 | 406 |
| Minor procedure (skin) | 17110 | 1,537 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 min | in_clinic | 180.00 EUR |
| Minor procedure (skin) | 30 min | in_clinic | 450.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 10 · i10: 9
-
Long-term follow-up of Oncology across GB
DOI: 10.7777/euroclin.2026.0 · PMID: 36442935 · cited by 104
-
Validation of clinical scoring in Oncology
DOI: 10.7872/euroclin.2025.1 · PMID: 31781554 · cited by 130
-
Long-term follow-up of Oncology across GB
DOI: 10.6949/euroclin.2024.2 · PMID: 31135965 · cited by 100
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
- 🏆 Young Investigator Award · European Society · 2023 · international
Society memberships
- WONCA Europe — Family Doctors — Member · since 2024
- national college of family doctors — Member · since 2024
- European Union of Medical Specialists (UEMS) — Member · since 2024
Patient reviews
- Bedside Manner
- 4.96
- Knowledge
- 4.99
- Wait Time
- 4.66
- Staff Friendliness
- 4.93
- Ease Of Appointment
- 4.81
- Value For Money
- 4.83
- Would Recommend Pct
- 97
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · crispin.thomas.hiley@euroclinics.example
- Accepted intl insurance
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
